bioRxiv Science⌕ Search

Biology subjects

Castro-Portuguez, R.

Publications and source records attributed to Castro-Portuguez, R..

5 recordsLinked to original sources

Kynurenine Metabolism Mediates Tumor Progression in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is characterized by dysregulation of the kynurenine pathway (KP), which converts tryptophan to NAD+ while generating immunomodulatory metabolites. Therapeutic efforts have focused on inhibiting IDO1 at the pathway entry point, but the functional consequences of targeting downstream KP enzymes remain poorly characterized. We used CRISPR/Cas9 to generate knockouts of three KP enzymes in the RENCA murine RCC model--kynurenine 3-monooxygenase (KMO), quinolinic acid phosphoribosyltransferase (QPRT), and 3-hydroxyanthranilic acid dioxygenase (HAAO)--and evaluated effects on cell migration, colony formation, tumor burden, metastasis, and survival. KMO and QPRT knockouts consistently reduced migratory capacity and colony size in vitro. However, in vivo effects were distinct: while QPRT knockout reduced tumor burden, KMO knockout did not. Notably, we did not detect metastasis in female mice receiving KMO knockout RENCA cells. HAAO knockout produced divergent effects, increasing migration and colony size in vitro, but reducing tumor burden and metastasis in vivo. Mice challenged orthotopically with all three knockout cell lines had significantly extended survival compared to mice receiving wild type cells. These results indicate that individual KP enzymes exert distinct, context-dependent effects on RCC progression. The enhanced in vitro aggressiveness coupled with reduced in vivo tumorigenicity observed in HAAO knockout RENCA cells illustrates that cell culture phenotypes do not reliably predict tumor behavior, particularly when perturbing metabolic pathways with pleiotropic effects. Our findings suggest that targeting specific KP enzymes warrants further investigation as a therapeutic strategy in RCC.

cancer biology↗

The Emerging Role of 3-Hydroxyanthranilic Acid on C. elegans Aging Immune Function

3-hydroxyanthranilic acid (3HAA) is considered to be a fleeting metabolic intermediate along tryptophan catabolism through the kynurenine pathway. 3HAA and the rest of the kynurenine pathway have been linked to immune response in mammals yet whether it is detrimental or advantageous is a point of contention. Recently we have shown that accumulation of this metabolite, either through supplementation or prevention of its degradation, extends healthy lifespan in C. elegans and mice, while the mechanism remained unknown. Utilizing C. elegans as a model we investigate how 3HAA and haao-1 inhibition impact the host and the potential pathogens. What we find is that 3HAA improves host immune function with aging and serves as an antimicrobial against gram-negative bacteria. Regulation of 3HAAs antimicrobial activity is accomplished via tissue separation. 3HAA is synthesized in the C. elegans hypodermal tissue, localized to the site of pathogen interaction within the gut granules, and degraded in the neuronal cells. This tissue separation creates a new possible function for 3HAA that may give insight to a larger evolutionarily conserved function within the immune response. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=141 SRC="FIGDIR/small/574394v2_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@3d74d1org.highwire.dtl.DTLVardef@c079c7org.highwire.dtl.DTLVardef@7b1f2eorg.highwire.dtl.DTLVardef@13c3eb3_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology↗

Inhibition of haao-1 enhances oxidative stress response by activating hormetic redox signaling in C. elegans.

3-hydroxyanthranilate 3,4-dioxygenase (HAAO) is an intermediate enzyme in the conversion from tryptophan (TRP) to nicotinamide adenine dinucleotide (NAD+) via the kynurenine pathway. The kynurenine pathway is the sole de novo NAD+ biosynthetic pathway from ingested tryptophan. Inhibition of several enzymatic steps in the kynurenine pathway increases lifespan in Drosophila melanogaster, Saccharomyces cerevisiae, and Caenorhabditis elegans. Knockout or knockdown of haao-1, the C. elegans gene encoding HAAO, or supplementation of its substrate metabolite 3-hydroxyanthranilic acid (3HAA), has been shown to promote healthy lifespan extension; however, the underlying mechanism remains unknown. In the present study, we report that haao-1 knockdown induces oxidative stress resistance against several reactive oxygen species (ROS) inducing agents by activating the Nrf2/SKN-1 oxidative stress response pathway. An examination of the redox state of animals with reduced haao-1 suggests that activation of the Nrf2/SKN-1 pathway is mediated by shifting the balance toward generation of ROS, generating a hormetic effect. Our results identify a novel mechanism for an endogenous metabolite (3HAA) that activates the oxidative stress response. These results provide a conceptual basis by which modulation of the kynurenine pathway can promote healthy aging and enhanced stress resistance. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/528568v1_ufig1.gif" ALT="Figure 1"> View larger version (73K): org.highwire.dtl.DTLVardef@1563682org.highwire.dtl.DTLVardef@114917dorg.highwire.dtl.DTLVardef@15bc7f2org.highwire.dtl.DTLVardef@a42023_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIKnockdown of haao-1 promotes oxidative stress resistance. C_LIO_LIKnockdown of haao-1 activates the Nrf2/SKN-1 oxidative stress response. C_LIO_LIThe shift in redox balance in haao-1 knockout animals suggests a hormetic mechanism for oxidative stress resistance. C_LI

molecular biology↗

3-hydroxyanthranilic acid - a new metabolite for healthy lifespan extension

The metabolism of tryptophan to nicotinamide adenine dinucleotide (NAD+) through the kynurenine pathway is increasingly linked to aging and age-associated disease. Kynurenine pathway enzymes and metabolites influence a range of molecular processes critical to healthy aging, including regulation of inflammatory and immune responses, cellular redox homeostasis, and energy production. Aberrant kynurenine metabolism is observed during normal aging and has been implicated in a range of age-associated pathologies, including chronic inflammation, atherosclerosis, neurodegeneration, and cancer. In previous work, we and others identified three genes--kynu-1, tdo-2, and acsd-1--encoding kynurenine pathway enzymes for which decreasing expression extends lifespan in invertebrate models. Here we report that knockdown of haao-1, a fourth kynurenine pathway gene encoding the enzyme 3-hydroxyanthranilic acid dioxygenase (HAAO), extends lifespan by ~30% and delays age-associated decline in health in Caenorhabditis elegans. This lifespan extension is mediated by increased physiological levels of the HAAO substrate 3-hydroxyanthranilic acid (3HAA). 3HAA increases resistance to oxidative stress during aging by directly degrading hydrogen peroxide and activating the Nrf2/SKN-1 oxidative stress response. Aging mice fed a diet supplemented with 3HAA are similarly long-lived. Our results identify HAAO and 3HAA as novel therapeutic targets for age-associated disease. This works provides a foundation for more detailed examination of the molecular mechanisms underlying the benefits of 3HAA, and how these mechanisms interact with other interventions both within and beyond the kynurenine pathway. We anticipate that these findings will bolster growing interest in developing pharmacological strategies to target tryptophan metabolism to improve health aging.

molecular biology↗

Breast tumor stiffness instructs bone metastasis via mechanical memory

The mechanical microenvironment of primary breast tumors plays a substantial role in promoting tumor progression. While the transitory response of cancer cells to pathological stiffness in their native microenvironment has been well described, it is still unclear how mechanical stimuli in the primary tumor influence distant, late-stage metastatic phenotypes across time and space in absentia. Here, we show that primary tumor stiffness promotes stable, non-genetically heritable phenotypes in breast cancer cells. This mechanical memory instructs cancer cells to adopt and maintain increased cytoskeletal dynamics, traction force, and 3D invasion in vitro, in addition to promoting osteolytic bone metastasis in vivo. Furthermore, we established a mechanical conditioning (MeCo) score comprised of mechanically-regulated genes as a global gene expression measurement of tumor stiffness response. Clinically, we show that a high MeCo score is strongly associated with bone metastasis in patients. Using a discovery approach, we mechanistically traced mechanical memory in part to ERK-mediated mechanotransductive activation of RUNX2, an osteogenic gene bookmarker and bone metastasis driver. The combination of these RUNX2 traits permits the stable transactivation of osteolytic target genes that remain upregulated after cancer cells disseminate from their activating microenvironment in order to modify a distant microenvironment. Using genetic, epigenetic, and functional approaches, we were able to simulate, repress, select and extend RUNX2-mediated mechanical memory and alter cancer cell behavior accordingly. In concert with previous studies detailing the influence of biochemical properties of the primary tumor stroma on distinct metastatic phenotypes, our findings detailing the influence of biomechanical properties support a generalized model of cancer progression in which the integrated properties of the primary tumor microenvironment govern the secondary tumor microenvironment, i.e., soil instructs soil.

cancer biology↗